OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis, Nature, vol.397, pp.315-323, 1999. ,
DOI : 10.1038/16852
Osteoprotegerin ligand: A common link between osteoclastogenesis, lymph node formation and lymphocyte development, Immunol. Cell Biol, vol.77, pp.188-193, 1999. ,
DOI : 10.1046/j.1440-1711.1999.00815.x
The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development, Cell, vol.103, pp.41-50, 2000. ,
DOI : 10.1016/s0092-8674(00)00103-3
URL : https://doi.org/10.1016/s0092-8674(00)00103-3
Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE, J. Exp. Med, vol.192, pp.1467-1478, 2000. ,
Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene, Proc. Natl. Acad. Sci, vol.97, pp.10905-10910, 2000. ,
Osteoclast precursors, RANKL/RANK, and immunology, Immunol. Rev, vol.208, pp.19-29, 2005. ,
DOI : 10.1111/j.0105-2896.2005.00336.x
Expression pattern changes and function of RANKL during mouse lymph node microarchitecture development, Int. Immunol, vol.24, pp.369-378, 2012. ,
DOI : 10.1093/intimm/dxs002
URL : https://academic.oup.com/intimm/article-pdf/24/6/369/17414641/dxs002.pdf
Biology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond. Front. Immunol, vol.5, 2014. ,
Receptor Activator of NF-?B Orchestrates Activation of Antiviral Memory CD8 T Cells in the Spleen Marginal Zone, vol.21, pp.2515-2527, 2017. ,
The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator, Immunity, vol.29, pp.438-450, 2008. ,
DOI : 10.1016/j.immuni.2008.06.018
URL : https://doi.org/10.1016/j.immuni.2008.06.018
Developmentally regulated availability of RANKL and CD40 ligand reveals distinct mechanisms of fetal and adult cross-talk in the thymus medulla, J. Immunol, vol.189, pp.5519-5526, 2012. ,
Emerging Functions of RANKL in Lymphoid Tissues. Front ,
, J. Clin. Med, vol.7, pp.426-437, 2018.
RANKL Induces Organized Lymph Node Growth by Stromal Cell Proliferation, J. Immunol, vol.188, pp.1245-1254, 2012. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00782725
Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit, Proc. Natl. Acad. Sci, vol.108, pp.5342-5347, 2011. ,
Rank, and Rankl in tooth development: Co-ordination of odontogenesis and osteogenesis, J. Dent. Res, vol.83, pp.241-244, 2004. ,
Bone resorption control of tooth eruption and root morphogenesis: Involvement of the receptor activator of NF-?B (RANK), J. Cell. Physiol, vol.226, pp.74-85, 2011. ,
Receptor activator of NF-kappaB ligand regulates the proliferation of mammary epithelial cells via Id2, Mol. Cell. Biol, vol.26, pp.1002-1013, 2006. ,
What signals operate in the mammary niche? Breast Dis, vol.29, pp.69-82, 2008. ,
Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues, vol.25, pp.525-534, 1999. ,
Immunolocalization of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin (OPG) in Meckel's cartilage compared with developing endochondral bones in mice, J. Anat, vol.207, pp.325-337, 2005. ,
Matrix-embedded cells control osteoclast formation, Nat. Med, vol.17, pp.1235-1241, 2011. ,
DOI : 10.1038/nm.2448
URL : http://europepmc.org/articles/pmc3192296?pdf=render
The cast of clasts: Catabolism and vascular invasion during bone growth, repair, and disease by osteoclasts, chondroclasts, and septoclasts, Connect. Tissue Res, vol.57, pp.161-174, 2016. ,
RANKL expression is related to the differentiation state of human osteoblasts, J. Bone Miner. Res, vol.18, pp.1088-1098, 2003. ,
Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL, Nat. Genet, vol.39, pp.960-962, 2007. ,
Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period, vol.64, pp.314-325, 2014. ,
Skeletal consequences of RANKL-blocking antibody (IK22-5) injections during growth: Mouse strain disparities and synergic effect with zoledronic acid, vol.73, pp.51-59, 2015. ,
Biological effects of anti-RANKL antibody administration in pregnant mice and their newborns, Biochem. Biophys. Res. Commun, vol.491, pp.614-621, 2017. ,
First inducible transgene expression in porcine large animal models, FASEB J, vol.26, pp.1086-1099, 2012. ,
DOI : 10.1096/fj.11-185041
Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis, J. Bone Miner. Metab, vol.20, pp.337-344, 2002. ,
DOI : 10.1007/s007740200049
, J. Clin. Med, vol.7, pp.426-438, 2018.
Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis, Nat. Genet, vol.24, pp.45-48, 2000. ,
Familial expansile osteolysis in a large Spanish kindred resulting from an insertion mutation in the TNFRSF11A gene, J. Med. Genet, 2002. ,
Role of RANKL (TNFSF11)-dependent osteopetrosis in the dental phenotype of Msx2 null mutant mice, PLoS ONE, vol.8, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01538404
Determination of three isoforms of the receptor activator of nuclear factor-kappaB ligand and their differential expression in bone and thymus, Endocrinology, vol.142, pp.1419-1426, 2001. ,
RANK/RANKL/OPG Signalization Implication in Periodontitis: New Evidence from a RANK Transgenic Mouse Model, Front. Physiol, vol.8, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01547424
RANK/RANKL: Regulators of immune responses and bone physiology, Ann. N. Y. Acad. Sci, vol.1143, pp.123-150, 2008. ,
Mice Deficient in NF-?B p50 and p52 or RANK Have Defective Growth Plate Formation and Post-natal Dwarfism, Bone Res, vol.1, pp.336-345, 2013. ,
RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization ,
Feto-maternal bone remodeling in normal pregnancy and preeclampsia, J. Soc. Gynecol. Investig, vol.12, pp.343-348, 2005. ,
Circulating osteoprotegerin and sRANKL concentrations in the perinatal period at term. The impact of intrauterine growth restriction, Neonatology, vol.96, pp.132-136, 2009. ,
Maternal circulating osteoprotegerin and soluble RANKL in pre-eclamptic women, Eur. J. Obstet. Gynecol. Reprod. Biol, vol.154, pp.141-145, 2011. ,
Expression of osteoprotegerin in placenta and its association with preeclampsia, PLoS ONE, vol.7, 2012. ,
Bone metabolism compensates for the delayed growth in small for gestational age neonates, Organogenesis, vol.9, pp.55-59, 2013. ,
,
Soluble receptors for advanced glycation end products and receptor activator of NF-?B ligand serum levels as markers of premature labor, BMC Pregnancy Childbirth, vol.15, 2015. ,
LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption, Nat. Med, vol.22, pp.539-546, 2016. ,
SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification, Dev. Camb. Engl, vol.137, pp.901-911, 2010. ,
, Curr. Top. Dev. Biol, vol.115, pp.31-58, 2015.
Msx1 is a regulator of bone formation during development and postnatal growth: In vivo investigations in a transgenic mouse model, Connect. Tissue Res, vol.43, pp.153-160, 2002. ,
Species-specific modifications of mandible shape reveal independent mechanisms for growth and initiation of the coronoid, EvoDevo, vol.6, 2015. ,
Dlx homeobox gene family expression in osteoclasts, J. Cell. Physiol, vol.223, pp.779-787, 2010. ,
The homeoprotein engrailed 1 has pleiotropic functions in calvarial intramembranous bone formation and remodeling, Dev. Camb. Engl, vol.133, pp.63-74, 2006. ,
, This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, © 2018 by the authors. Licensee MDPI